c-MET-Positive Circulating Tumor Cells and Cell-Free DNA as Independent Prognostic Factors in Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer
Ninety-seven patients with hormone receptor-positive metastatic breast cancer were prospectively enrolled during standard treatment at Samsung Medical Center.